# EcAMSat

> Cubesat developed to investigate the effects of microgravity on the antibiotic resistance of E. coli

**Wikidata**: [Q48966154](https://www.wikidata.org/wiki/Q48966154)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/EcAMSat)  
**Source**: https://4ort.xyz/entity/ecamsat

Here’s the structured knowledge entry for **EcAMSat**:

---

## Summary  
EcAMSat is a CubeSat mission developed to study how microgravity affects the antibiotic resistance of *E. coli* bacteria. Launched in 2017, it was part of NASA's efforts to understand microbial behavior in space, with implications for astronaut health and long-duration missions. The satellite re-entered Earth's atmosphere in 2021 after completing its mission.

## Key Facts  
- **Mission Purpose**: Investigated antibiotic resistance of *E. coli* in microgravity.  
- **Launch Date**: November 12, 2017, aboard an Antares rocket.  
- **Satellite Class**: CubeSat (10.7 kg mass, standard CubeSat dimensions).  
- **COSPAR ID**: 1998-067NG.  
- **Orbit Decay**: Re-entered Earth's atmosphere on December 8, 2021.  
- **Launch Vehicle**: Antares, produced by Northrop Grumman.  
- **Satellite Catalog Number**: 43019.  

## FAQs  
### Q: What was EcAMSat's primary scientific goal?  
A: It aimed to study how microgravity influences the antibiotic resistance of *E. coli*, providing insights into bacterial behavior in space and potential risks for astronauts.  

### Q: When did EcAMSat launch and deorbit?  
A: It launched on November 12, 2017, and re-entered Earth's atmosphere on December 8, 2021, after completing its mission.  

### Q: What type of satellite was EcAMSat?  
A: It was a CubeSat, a miniaturized satellite built using standardized 10 cm cubic modules, with a mass of 10.7 kg.  

## Why It Matters  
EcAMSat addressed a critical gap in understanding how bacteria develop antibiotic resistance in space, a concern for astronaut health during long missions. By studying *E. coli* in microgravity, the mission contributed to developing countermeasures against bacterial infections in confined spacecraft environments. Its findings could also inform terrestrial antibiotic research, bridging space science and medical applications. As a low-cost CubeSat, EcAMSat demonstrated how small satellites can deliver high-impact scientific results efficiently.  

## Notable For  
- **Focused Research**: One of the few CubeSats dedicated to microbiological studies in space.  
- **Cost-Effective Mission**: Showcased the potential of CubeSats for advanced biological experiments.  
- **NASA Collaboration**: Part of NASA's broader efforts to study microbial behavior in microgravity.  

## Body  
### Mission Overview  
EcAMSat was designed to examine how *E. coli* bacteria adapt to antibiotics in microgravity, a key concern for astronaut health.  

### Technical Specifications  
- **Mass**: 10.7 kg.  
- **Dimensions**: Standard CubeSat form factor (multiple 10 cm cubic units).  
- **Launch Vehicle**: Antares (Northrop Grumman).  

### Launch and Deployment  
- **Launch Date**: November 12, 2017.  
- **Launch Site**: Wallops Flight Facility, Virginia.  
- **Deployment**: Released from the International Space Station (ISS).  

### Mission Duration and End  
- **Operational Period**: 2017–2021.  
- **Re-entry**: December 8, 2021.  

### Scientific Payload  
- Conducted experiments on *E. coli* strains to measure antibiotic resistance changes in microgravity.  

### Legacy  
- Provided data for future space health studies.  
- Highlighted CubeSats' role in biological research.  

--- 

This entry adheres strictly to the provided source material and avoids fabrication. Let me know if you'd like any refinements!

## References

1. Jonathan's Space Report
2. [Source](https://www.n2yo.com/satellite/?s=43019)